These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 18076765)
1. On the analysis of glycomics mass spectrometry data via the regularized area under the ROC curve. Ye J; Liu H; Kirmiz C; Lebrilla CB; Rocke DM BMC Bioinformatics; 2007 Dec; 8():477. PubMed ID: 18076765 [TBL] [Abstract][Full Text] [Related]
2. Regularized binormal ROC method in disease classification using microarray data. Ma S; Song X; Huang J BMC Bioinformatics; 2006 May; 7():253. PubMed ID: 16684357 [TBL] [Abstract][Full Text] [Related]
3. The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery. Kronewitter SR; De Leoz ML; Strum JS; An HJ; Dimapasoc LM; Guerrero A; Miyamoto S; Lebrilla CB; Leiserowitz GS Proteomics; 2012 Aug; 12(15-16):2523-38. PubMed ID: 22903841 [TBL] [Abstract][Full Text] [Related]
4. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680 [TBL] [Abstract][Full Text] [Related]
5. A parsimonious threshold-independent protein feature selection method through the area under receiver operating characteristic curve. Wang Z; Chang YC; Ying Z; Zhu L; Yang Y Bioinformatics; 2007 Oct; 23(20):2788-94. PubMed ID: 17878205 [TBL] [Abstract][Full Text] [Related]
6. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995 [TBL] [Abstract][Full Text] [Related]
7. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. Hua S; Williams CC; Dimapasoc LM; Ro GS; Ozcan S; Miyamoto S; Lebrilla CB; An HJ; Leiserowitz GS J Chromatogr A; 2013 Mar; 1279():58-67. PubMed ID: 23380366 [TBL] [Abstract][Full Text] [Related]
8. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Wu B; Abbott T; Fishman D; McMurray W; Mor G; Stone K; Ward D; Williams K; Zhao H Bioinformatics; 2003 Sep; 19(13):1636-43. PubMed ID: 12967959 [TBL] [Abstract][Full Text] [Related]
9. Combining multiple markers for classification using ROC. Ma S; Huang J Biometrics; 2007 Sep; 63(3):751-7. PubMed ID: 17825007 [TBL] [Abstract][Full Text] [Related]
10. A Machine Learning Based Approach to de novo Sequencing of Glycans from Tandem Mass Spectrometry Spectrum. Kumozaki S; Sato K; Sakakibara Y IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(6):1267-74. PubMed ID: 26671799 [TBL] [Abstract][Full Text] [Related]
11. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786 [TBL] [Abstract][Full Text] [Related]
12. Predictive modeling in proteomics-based disease detection. Pham TD Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703 [TBL] [Abstract][Full Text] [Related]
13. Combining biomarkers linearly and nonlinearly for classification using the area under the ROC curve. Fong Y; Yin S; Huang Y Stat Med; 2016 Sep; 35(21):3792-809. PubMed ID: 27058981 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288 [TBL] [Abstract][Full Text] [Related]
15. A comparison of confidence/credible interval methods for the area under the ROC curve for continuous diagnostic tests with small sample size. Feng D; Cortese G; Baumgartner R Stat Methods Med Res; 2017 Dec; 26(6):2603-2621. PubMed ID: 26323286 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics in glycomics: glycan characterization with mass spectrometric data using SimGlycan. Apte A; Meitei NS Methods Mol Biol; 2010; 600():269-81. PubMed ID: 19882135 [TBL] [Abstract][Full Text] [Related]
17. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues. Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689 [TBL] [Abstract][Full Text] [Related]
18. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry. Sethi MK; Hancock WS; Fanayan S Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Kamiyama T; Yokoo H; Furukawa J; Kurogochi M; Togashi T; Miura N; Nakanishi K; Kamachi H; Kakisaka T; Tsuruga Y; Fujiyoshi M; Taketomi A; Nishimura S; Todo S Hepatology; 2013 Jun; 57(6):2314-25. PubMed ID: 23322672 [TBL] [Abstract][Full Text] [Related]
20. Hierarchical normalized cuts: unsupervised segmentation of vascular biomarkers from ovarian cancer tissue microarrays. Janowczyk A; Chandran S; Singh R; Sasaroli D; Coukos G; Feldman MD; Madabhushi A Med Image Comput Comput Assist Interv; 2009; 12(Pt 1):230-8. PubMed ID: 20425992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]